[HTML][HTML] The use of antenatal magnesium sulfate for neuroprotection for infants born prematurely
K Heyborne, WA Bowes Jr - F1000 medicine reports, 2010 - ncbi.nlm.nih.gov
Cerebral palsy occurs in three to four infants per 1000 live births. Preterm birth prior to 34
weeks' gestation is a major risk factor. Five randomized controlled trials of antenatal …
weeks' gestation is a major risk factor. Five randomized controlled trials of antenatal …
Magnesium sulfate for neuroprotection in patients at risk for early preterm delivery: not yet
BM Sibai - American Journal of Obstetrics & Gynecology, 2011 - ajog.org
The editors of the Journal and the SMFM Publication Committee are pleased to provide this
summary of a debate conducted at the 31st annual meeting of the Society for Maternal–Fetal …
summary of a debate conducted at the 31st annual meeting of the Society for Maternal–Fetal …
Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of …
S Marret, L Marpeau, C Follet-Bouhamed, G Cambonie… - 2008 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate whether magnesium sulphate (MgSO (4)) given to women at risk of
very-preterm birth would be neuroprotective in preterm newborns. Patients and methods In …
very-preterm birth would be neuroprotective in preterm newborns. Patients and methods In …
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus
LW Doyle, CA Crowther, P Middleton… - Cochrane database …, 2009 - cochranelibrary.com
Background Epidemiological and basic science evidence suggests that magnesium
sulphate before birth may be neuroprotective for the fetus. Objectives To assess the effects …
sulphate before birth may be neuroprotective for the fetus. Objectives To assess the effects …
Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double‐blind, randomised, placebo‐controlled, multi‐centre trial
HT Wolf, J Brok, TB Henriksen… - … Journal of Obstetrics …, 2020 - Wiley Online Library
Objective To study the effect of antenatal magnesium sulphate (MgSO4) on cerebral palsy
(CP) in a manner that also provides adequate power for a linked trial sequential analysis …
(CP) in a manner that also provides adequate power for a linked trial sequential analysis …
The use of intravenous magnesium in non-preeclamptic pregnant women: fetal/neonatal neuroprotection
Y Jacquemyn, A Zecic, D Van Laere… - Archives of gynecology …, 2015 - Springer
Purpose To review the effect of intravenous magnesium in obstetrics on fetal/neonatal
neuroprotection. Methods A systematic review of published studies. Results Five …
neuroprotection. Methods A systematic review of published studies. Results Five …
[HTML][HTML] Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis
Background The aim of this study was to assess the cost-effectiveness of administering
magnesium sulphate to patients in whom preterm birth at< 32+ 0 weeks gestation is either …
magnesium sulphate to patients in whom preterm birth at< 32+ 0 weeks gestation is either …
Prenatal treatment with magnesium sulphate: Initial clinical outcomes in pre-term infants less than 29 weeks and correlation with neonatal magnesium levels
LG Alonso, MP Prieto, EG Colmenero… - Anales de Pediatría …, 2017 - Elsevier
Abstract Introduction Antenatal magnesium sulphate (MgSO 4) administration has shown to
be effective in minimising cerebral palsy and severe motor dysfunction at the age of 2 years …
be effective in minimising cerebral palsy and severe motor dysfunction at the age of 2 years …
Neuroprotective effects of in utero exposure to magnesium sulfate
HN Simhan, KP Himes - En: UptoDate, Post Tw (Ed), UpToDate …, 2012 - uptodate.com
In utero exposure to magnesium sulfate before early preterm birth appears to decrease the
incidence and severity of cerebral palsy. Cerebral palsy is the leading cause of neurologic …
incidence and severity of cerebral palsy. Cerebral palsy is the leading cause of neurologic …
[HTML][HTML] Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: an individual participant data meta-analysis
Background Babies born preterm are at an increased risk of dying in the first weeks of life,
and those who survive have a higher rate of cerebral palsy (CP) compared with babies born …
and those who survive have a higher rate of cerebral palsy (CP) compared with babies born …